Product NDC: | 51672-1281 |
Proprietary Name: | Desonide |
Non Proprietary Name: | Desonide |
Active Ingredient(s): | .5 mg/g & nbsp; Desonide |
Administration Route(s): | TOPICAL |
Dosage Form(s): | OINTMENT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51672-1281 |
Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074254 |
Marketing Category: | ANDA |
Start Marketing Date: | 19940803 |
Package NDC: | 51672-1281-1 |
Package Description: | 1 TUBE in 1 CARTON (51672-1281-1) > 15 g in 1 TUBE |
NDC Code | 51672-1281-1 |
Proprietary Name | Desonide |
Package Description | 1 TUBE in 1 CARTON (51672-1281-1) > 15 g in 1 TUBE |
Product NDC | 51672-1281 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Desonide |
Dosage Form Name | OINTMENT |
Route Name | TOPICAL |
Start Marketing Date | 19940803 |
Marketing Category Name | ANDA |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Substance Name | DESONIDE |
Strength Number | .5 |
Strength Unit | mg/g |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |